Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients

Transfusion Medicine

Volumn 15, Issue 1, 2005, Pages 37-43

  Da Ponte, A ^a   Bidoli, E ^a   Talamini, R ^a   Steffan, A ^a   Abbruzzese, L ^a   Tassan Toffola, R ^a   De Marco, L ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

In line filtration; Leucodepletion; Transfusion reactions

Indexed keywords

ALLERGIC REACTION; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CONTROLLED STUDY; DEPLETION; ERYTHROCYTE; HEMOLYSIS; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY;

ADOLESCENT; ADULT; AGED; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; NEOPLASMS;

EID: 14544304102     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2005.00546.x     Document Type: Article

References (28)

1. Blajchman, M.A. (1999) Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion, 39, 665-670.
2. Blumberg, N., Heal, J.M. & Gettings, K.F. (2003) WBC reduction of RBC transfusions is associated with a decrease incidence of RBC alloimmunization. Transfusion, 43, 945-952.
3. Brecher, M.E., Triulzi, D.J. & Assmann, S.F. for the viral activation transfusion study. (2001) Number of RBC units and rate of transfusion to anemic HIV-positive patients assigned to receive WBC-reduced or non WBC-reduced RBCs: the Viral Activation Transfusion Study Experience. Transfusion, 41, 794-798.
4. Breslow, N.E. & Day, N.E. (1980) The analysis of case-control studies. Statistical Methods in Cancer Research, Vol. I. IARC Scientific publications, No. 32 International Agency for Research on Cancer, Lyon, France.
5. British Committee for Standards in Haematology, Blood Transfusion Task Force. (1998) Guidelines on the clinical use of leucocyte-depleted blood components. Transfusion Medicine, 8, 59-71.
6. Chabanel, A., Andreu, G., Carrat, F. & Hervè, P. (2002) Quality control of leucoreduced cellular blood components in France. Vox Sanguinis, 82, 67-71.
7. Dolcetti, R., Martini, F., Quaia, M., Gloghini, A., Vignocchi, B., Cariati, R., Martinelli, M., Carbone, A., Boiocchi, M. & Tognon, M. (2003) Simian virus 40 sequences in human lymphoblastoid B-cell lines. Journal of Virology, 77, 1595-1597.
8. Dzik, S. (1997) Principles of counting low numbers of leukocytes in leukoreduced blood components. Transfusion Medicine Reviews, 11, 44-55.
9. Dzik, W.H. (2002) Leukoreduction of blood components. Current Opinion in Hematology, 9, 521-526.
10. Dzik, S., Anderson, J.K., O'Neill, E.M., Assmann, S.F., Kalish, L.A. & Stowell, C.P. (2002) A prospective, randomized clinical trial of universal WBC reduction. Transfusion, 42, 1114-1122.
11. Dzik, S., Aubuchon, J., Jeffries, L., Kleiman, S., Manno, C., Murphy, M.F., Popovsky, M.A., Sayers, M., Silberstein, L.E., Slichter, S.J. & Vamvakas, E.C. (2000) Leukocyte reduction of blood components: public policy and new technology. Transfusion Medicine Reviews, 14, 34-52.
12. Federowicz, I., Barrett, B.B., Andersen, J.W., Urashima, M., Popovsky, M.A. & Anderson, K.C. (1996) Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion, 36, 21-28.
13. Kopko, P.M. & Holland, P.V. (2000) Universal leukocyte reduction. Current Opinion in Hematology, 7, 397-401.
14. Murphy, M.F. (1999) New variant Creutzfeldt-Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components. Transfusion Medicine Reviews, 13, 75-83.
15. Nichols, W.G., Price, T.H., Gooley, T., Corey, L. & Boeckh, M. (2003) Transfusion-transmitted cytomegaloviurs infection after receipt of leukoreduced blood products. Blood, 101, 4195-4200.
16. Nightingale, S.D. (2001) Universal WBC reduction. Transfusion, 41, 1306-1309.
17. Ratko, T.A., Cummings, J.P., Oberman, H.A., Crookston, K.P., DeChristopher, P.J., Eastlund, D.T., Godwin, J.E., Sacher, R.A., Yawn, D.H. & Matuszewski, K.A. (2001) Evidence-based recommendations for the use of WBC-reduced cellular blood components. Transfusion, 41, 1310-1319.
18. Roddie, P.H., Turner, M.L. & Williamson, L.M. (2000) Leucocyte depletion of blood components. Blood Reviews, 14, 145-156.
19. Shiba, M., Tadokoro, K., Sawanobori, M., Nakajima, K., Suzuki, K. & Juji, T. (1997) Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion, 37, 457-462.
20. Sirchia, G., Rebulla, P., Sabbioneda, L., Garcea, F. & Greppi, N. (1996) Optimal conditions for white cell reduction in red cells by filtration at the patient's bedside. Transfusion, 36, 322-327.
21. Uhlmann, E.J., Isgriggs, E., Wallhermfechtel, M. & Goodnough, L.T. (2001) Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion, 41, 997-1000.
22. Vamvakas, E.C. (2003) WBC-containing allogenic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion, 43, 963-973.
23. Vamvakas, E.C. & Blajchman, M.A. (2001) Universal WBC reduction: the case for and against. Transfusion, 41, 691-712.
24. Van Der Meer, P.F., Gratama, J.W., Van Delden, C.J., Laport, R.F., Levering, H.B.M., Schrijver, J.G., Tiekstra, M.J., Keeney, M. & de Wildt-Eggen, J. (2001) Comparison of five platforms for enumeration of residual leukocytes in leucoreduced blood components. British Journal of Haematology, 115, 953-962.
25. Vilchez, R.A., Madden, C.R., Kozinetz, C.A., Halvorson, S.J., White, Z.S., Jorgensen, J.L., Finch, C.J. & Butel, J.S. (2002) Association between simian virus 40 and non-Hodgkin's lymphoma. Lancet, 359, 817-822.
26. Williamson, L.M. (2000) Leucocyte depletion of blood supply - how will patients benefit? British Journal of Haematology, 110, 256-272.
27. Williamson, L.M., Rider, J.R., Swann, I.D., Winter, M.A., Ali, F. & Pamphilon, D.H. (1999) Evaluation of plasma and red cells obtained after leukocyte depletion of whole blood. Transfusion Medicine, 9, 51-61.
28. Yomtovian, R., Gernsheimer, T., Assmann, S.F., Mohandas, K., Lee, T.-H., Kalish, L.A. & Busch, M.P. for the Viral Activation Transfusion Study Group. (2001) WBC reduction in RBC concentrates by prestorage filtration: multicenter experience. Transfusion, 41, 1030-1036.